In this study, we observed that the expression of SOX2, but not OCT4 and NANOG, correlates with poor histological differentiation of endometrial tumors, associates with lymph node metastasis, and predicts a poor survival in patients. The gene discussed is SOX2; the disease is metastatic malignant neoplasm in the lymph nodes.